Mitochondria and degenerative disorders

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 106, Issue 1, 2001, Pages 27-36

  Orth, M ^b   Schapira, A H V ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

Alzheimer disease; Amyotrophic lateral sclerosis; Friedreich ataxia; Hereditary spastic paraparesis; Huntington disease; Mitochondria; Neurodegenerative disorders; Parkinson disease; Wilson disease

Indexed keywords

CELL PROTEIN; FRATAXIN; FREE RADICAL; HUNTINGTIN; MITOCHONDRIAL DNA; PARAPLEGIN; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; DEGENERATIVE DISEASE; ENERGY METABOLISM; EXTERNAL OPHTHALMOPLEGIA; FRIEDREICH ATAXIA; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LEIGH DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; CELL NUCLEUS; HEPATOLENTICULAR DEGENERATION; HUMANS; HUNTINGTON DISEASE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; NEURODEGENERATIVE DISEASES; OXYGEN; PARKINSON DISEASE; PHOSPHORYLATION; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 0034962860     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1425     Document Type: Article

References (154)

1. Iron-dependent self-assembly of recombinant yeast frataxin: Implications for Friedreich's ataxia
2. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease
3. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis
4. Complex I defect in muscle from patients with Huntington's disease
5. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
6. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: Implications for Parkinson's disease
7. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
8. X-linked spastic paraplegia (SPG2): Clinical heterogeneity at a single gene locus
9. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function
10. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death
11. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
12. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
13. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
14. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
15. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
16. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells
17. 2+) overload and ROS generation in spinal motor neurons in vitro
18. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease
19. Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease
20. Cu,Zn-super-oxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells
21. Parkinson's disease: A new link between mono-amine oxidase and mitochondrial electron flow
22. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: A role for mitochondrial complex I activity
23. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
24. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease
25. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3
26. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy
27. Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: An HPLC and ESR study
28. Mitochondrial DNA deletion mutation levels are elevated in ALS brains
29. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
30. Mitochondrial DNA mutations in human disease
31. Prevalence of hereditary ataxias and spsatic paraplegias in Molise, a region of Italy
32. Advances in hereditary spastic paraplegia
33. Autosomal dominant spastic paraplegia: Tight linkage to chromosome 15q
34. Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain
35. Inhibition of ICE slows ALS in mice
36. Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis
37. Spastic paraplegia, epilepsy, and mental retardation in several members of a family: A novel genetic disorder
38. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
39. Evidence of neuronal oxidative damage in Alzheimer's disease
40. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
41. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cell in-vitro
42. Mitochondrial defect in Huntington's disease caudate nucleus
43. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases
44. Oxidative-phosphorylation defects in liver of patients with Wilson's disease
45. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
46. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
47. Iron toxicity and oxygen radicals
48. Friedreich's Ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features
49. Genetic aspects of autosomal dominant late onset cerebellar ataxia
50. Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm
51. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts
52. Autosomal dominant familial spastic paraplegia is genetically heterogenous and one locus maps to chromosome 14q
53. Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p
54. Linkage of "pure" autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic loci heterogeneity
55. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes
56. Biochemical pathophysiology of Parkinson's disease
57. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae
58. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
59. 1H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
60. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene
61. Chronic mitochonrial inhibition induces selective motoneuron death in vitro: A new model for amyotrophic lateral sclerosis
62. Alzheimer's disease
63. Modulation of brain mitochondrial membrane permeability and synaptosomal Ca2+ transport by dopamine oxidation
64. Brain cytochrome oxidase in Alzheimer's disease
65. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: A nonspecific change?
66. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
67. Mice deficient in cellular glutathion peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
68. Human deafness dystonia syndrome is a mitochondrial disease
69. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
70. 10
71. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction
72. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease
73. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
74. Studies of human, mouse and yeast homologoues indicate a mitochondrial function for frataxin
75. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
76. Effects of endogenous and exogenous antioxidants on 3-nitropropionic acid -induced in vivo oxidative stress and striatal lesions: Insight into Huntington's disease
77. The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases
78. Chronic parkinsonism in humans due to a product of meperidine analog synthesis
79. The ubiquitin pathway in Parkinson's disease
80. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
81. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
82. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
83. Association of late onset spastic paraparesis and dementia: Probably an autosomal dominant form of complicated paraplegia
84. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
85. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia
86. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome
87. Localization of the Wilson's disease protein product to mitochondria
88. Mitochondrial function and parental sex effect in Huntington's disease
89. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
90. Mitochondrial tRNA(Gln) and tRNA(Thr) gene variants in Parkinson's disease
91. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor
92. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
93. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
94. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-phenylpyridinium ion
95. Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEC rat hepatocytes
96. Towards a structural understanding of Friedreich's ataxia: The solution structure of frataxin
97. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease
98. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
99. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene
100. Cytochrome c oxidase in Alzheimer's disease brain: Purification and characterization
101. Cytochrome oxidase deficiency in Alzheimer's disease
102. Electron transport chain defects in Alzheimer's disease brain
103. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
104. Srriatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease
105. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex
106. Hereditary "pure" spastic paraplegia: A study of nine families
107. Mutation in the α-synuclein gene identified in families with Parkinson's disease
108. The yeast frataxin homologue mediates mitochondrial iron efflux
109. Mitochondria, oxygen free radicals and apoptosis
110. Energy dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4phenyl 1,2,3,6 tetrahydropyridine, by mitochondria
111. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
112. Pure hereditary spastic paraplegia
113. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
114. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia
115. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study
116. A marker of oxydoradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain
117. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease
118. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic at the proteolipid protein locus
119. Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarisation
120. Localization of the Wilson's disease protein in human liver
121. 1 reductase (complex I) deficiency in Parkinson's disease
122. Mitochondria in the etiology and pathogenesis of Parkinson's disease
123. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
124. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy
125. Cloning of a gene bearing missense mutation in early-onset familial Alzheimer's disease
126. Increased 8-oxo-dGTPase in the mitochondria of substantia nigra neurons in Parkinson's disease
127. Cytochrome c oxidase deficiency
128. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis
129. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease
130. Oxidative damage in Alzheimer's
131. Oxidant injury to hepatic mitochondrial lipids in rats with dietary, copper overload. Modification by vitamin E deficiency
132. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis
133. Alpha-synuclein in Lewy bodies
134. Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease
135. An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats
136. Origin and functional consequences of the complex i defect in Parkinson's disease
137. Cybrids in Alzheimer's disease: A cellular model of the disease?
138. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients
139. Biochemical abnormalities and excitotoxicity in Huntington's disease brain
140. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 trangenic mouse
141. Dopa and dopamine cause cultured neuronal death in the presence of iron
142. Parkinson disease in twins: An etiologic study
143. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency
144. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I
145. Respiratory chain complex I deficiency
146. Mutations of the SOC1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy
147. A mutation in the human heme A:farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency
148. Demonstration of a new pathogenic mutation in human complex I deficiency: A 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit
149. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways
150. Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations
151. A family with hereditary spastic paraparesis and epilepsy
152. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
153. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity
154. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome